News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
473,918 Results
Type
Article (45804)
Company Profile (32)
Press Release (428081)
Multimedia
Podcasts (69)
Webinars (11)
Section
Business (117016)
Career Advice (1764)
Deals (19865)
Drug Delivery (63)
Drug Development (56029)
Employer Resources (132)
FDA (9246)
Job Trends (10359)
News (202929)
Policy (17264)
Tag
Academia (2693)
Academic (1)
Accelerated approval (4)
Adcomms (14)
Allergies (78)
Alliances (25659)
ALS (74)
Alzheimer's disease (1214)
Antibody-drug conjugate (ADC) (92)
Approvals (9307)
Artificial intelligence (181)
Autoimmune disease (16)
Automation (6)
Bankruptcy (165)
Best Places to Work (8882)
BIOSECURE Act (14)
Biosimilars (61)
Biotechnology (32)
Bladder cancer (62)
Brain cancer (24)
Breast cancer (277)
Cancer (2019)
Cardiovascular disease (186)
Career advice (1508)
Career pathing (19)
CAR-T (116)
CDC (25)
Cell therapy (336)
Cervical cancer (14)
Clinical research (45129)
Collaboration (573)
Company closure (2)
Compensation (196)
Complete response letters (10)
COVID-19 (1920)
CRISPR (44)
C-suite (255)
Cystic fibrosis (74)
Data (2513)
Decentralized trials (1)
Denatured (10)
Depression (46)
Diabetes (229)
Diagnostics (4567)
Digital health (11)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (80)
Drug pricing (71)
Drug shortages (14)
Duchenne muscular dystrophy (84)
Earnings (43297)
Editorial (30)
Employer branding (21)
Employer resources (114)
Events (109411)
Executive appointments (659)
FDA (10341)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (578)
Gene editing (105)
Generative AI (15)
Gene therapy (266)
GLP-1 (482)
Government (2721)
Grass and pollen (4)
Guidances (150)
Healthcare (13897)
Huntington's disease (18)
IgA nephropathy (34)
Immunology and inflammation (98)
Immuno-oncology (6)
Indications (30)
Infectious disease (2033)
Inflammatory bowel disease (119)
Inflation Reduction Act (5)
Influenza (40)
Intellectual property (66)
Interviews (313)
IPO (11466)
IRA (27)
Job creations (1776)
Job search strategy (1263)
Kidney cancer (9)
Labor market (23)
Layoffs (243)
Leadership (13)
Legal (4147)
Liver cancer (57)
Lung cancer (269)
Lymphoma (159)
Machine learning (7)
Management (41)
Manufacturing (205)
MASH (73)
Medical device (9985)
Medtech (9987)
Mergers & acquisitions (8817)
Metabolic disorders (547)
Multiple sclerosis (70)
NASH (12)
Neurodegenerative disease (85)
Neuropsychiatric disorders (25)
Neuroscience (1702)
NextGen: Class of 2025 (4938)
Non-profit (3406)
Now hiring (9)
Obesity (241)
Opinion (171)
Ovarian cancer (72)
Pain (50)
Pancreatic cancer (84)
Parkinson's disease (140)
Partnered (13)
Patents (148)
Patient recruitment (95)
Peanut (37)
People (42433)
Pharmaceutical (9)
Pharmacy benefit managers (6)
Phase I (14304)
Phase II (20016)
Phase III (14548)
Pipeline (1160)
Policy (135)
Postmarket research (1949)
Preclinical (7163)
Press Release (36)
Prostate cancer (79)
Psychedelics (25)
Radiopharmaceuticals (199)
Rare diseases (313)
Real estate (3104)
Recruiting (58)
Regulatory (11943)
Reports (28)
Research institute (2084)
Resumes & cover letters (278)
Rett syndrome (5)
RNA editing (4)
RSV (32)
Schizophrenia (63)
Series A (104)
Series B (67)
Service/supplier (2)
Sickle cell disease (50)
Special edition (8)
Spinal muscular atrophy (168)
Sponsored (22)
Startups (2195)
Stomach cancer (6)
Supply chain (26)
Tariffs (33)
The Weekly (57)
Vaccines (523)
Venture capital (34)
Weight loss (142)
Women's health (24)
Worklife (15)
Date
Today (28)
Last 7 days (269)
Last 30 days (1240)
Last 365 days (21763)
2025 (11713)
2024 (25586)
2023 (30769)
2022 (38465)
2021 (42235)
2020 (40167)
2019 (36017)
2018 (26167)
2017 (20475)
2016 (20494)
2015 (24821)
2014 (19276)
2013 (16489)
2012 (17408)
2011 (17681)
2010 (16312)
Location
Africa (596)
Alabama (45)
Alaska (7)
Arizona (106)
Arkansas (11)
Asia (25882)
Australia (4983)
California (5001)
Canada (1592)
China (425)
Colorado (226)
Connecticut (239)
Delaware (115)
Europe (64271)
Florida (732)
Georgia (231)
Idaho (40)
Illinois (447)
India (11)
Indiana (236)
Iowa (11)
Japan (148)
Kansas (78)
Kentucky (15)
Louisiana (11)
Maine (65)
Maryland (708)
Massachusetts (3920)
Michigan (137)
Minnesota (325)
Mississippi (2)
Missouri (61)
Montana (21)
Nebraska (18)
Nevada (63)
New Hampshire (36)
New Jersey (1432)
New Mexico (15)
New York (1415)
North Carolina (796)
North Dakota (6)
Northern California (2212)
Ohio (178)
Oklahoma (8)
Oregon (26)
Pennsylvania (1087)
Puerto Rico (8)
Rhode Island (17)
South America (769)
South Carolina (23)
Southern California (1962)
Tennessee (73)
Texas (772)
United States (18985)
Utah (150)
Virginia (109)
Washington D.C. (52)
Washington State (477)
West Virginia (4)
Wisconsin (33)
473,918 Results for "university at buffalo".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.
January 24, 2024
·
4 min read
Press Releases
IonQ and the University of Washington Simulate Process Linked To The Universe’s Matter-Antimatter Imbalance
June 25, 2025
·
7 min read
Genetown
Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo
Activ Surgical™, a digital surgery pioneer, announced the successful completion of an Institutional Review Board study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York.
May 24, 2022
·
4 min read
Deals
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
As the antibody-drug conjugate space continues to heat up, Merck has acquired preclinical startup Abceutics—spun out of the University at Buffalo—and its novel platform that aims to make ADC therapeutics safer.
April 8, 2024
·
2 min read
·
Tristan Manalac
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio
July 9, 2025
·
7 min read
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
·
6 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Business
Athenex Files for Bankruptcy, Cuts 123 Jobs Across New York
Athenex announced it will lay off 79 employees in Buffalo and 44 employees in Clarence as a result of the Chapter 11 filing.
May 17, 2023
·
2 min read
·
Rosemary Scott
Business
Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute
Synchron today announced the COMMAND trial is commencing at Gates Vascular Institute, a Kaleida Health facility in Buffalo, N.Y. and teaching affiliate of the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB).
March 20, 2023
·
5 min read
1 of 47,392
Next
